| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/31/2008 | US20080184392 Transforming a plant cell with a nucleic acid sequence that encodes the acquired resistance polypeptide, regenerating a plant from the transformed plant cell; resistance to fungal pathogens |
| 07/31/2008 | US20080184391 Pathogen resistant transgenic plants, associated nucleic acids and techniques involving the same |
| 07/31/2008 | US20080184390 Expression cassettes for mesophyll-and/or epidermis-preferential expression in plants |
| 07/31/2008 | US20080184389 Maize promoter p95 and methods of use |
| 07/31/2008 | US20080184388 Zea mays provides a high level of specificity for expression in developing pollen; plants comprising suppressed male fertility genes, useful as females in hybrid plant production; useful for generating fertile parental plants that, when crossed generate sterile progeny plants |
| 07/31/2008 | US20080184387 in plants obtainable from Arabidopsis thaliana genes; for alteration of the function of root tissue, modification of growth rate, improvement of resistance to root preferred pathogens, pests, herbicides or adverse weather conditions, for detoxification of soil as well as for broadening the range of soils |
| 07/31/2008 | US20080184386 Plant genome sequences and uses thereof |
| 07/31/2008 | US20080184385 Use of GmRD22-like genes to protect against abiotic stress |
| 07/31/2008 | US20080184384 particularly plants and cell-based systems for the bioproduction of useful compounds, including recombinant proteins, biofuels, food supplements |
| 07/31/2008 | US20080184383 Lettuce line p2428-5006090 |
| 07/31/2008 | US20080184381 Schizophrenia-related voltage-gated ion channel gene and protein |
| 07/31/2008 | US20080184380 Suppression of Endogenous Immunoglobulin Expression in Non-Human Transgenic Animals |
| 07/31/2008 | US20080184379 screening inductive promoting substances of anti-viral proteins such as interferon-beta against lipopolysaccharide stimulation or viral infection by using TBK1 knockout mice, or the tissues or cells derived therefrom |
| 07/31/2008 | US20080183123 nucleic acid composition for injection; ciliary body tissue(s) or cells and/or to the extra-ocular muscle tissue or cells; antiproliferative, antiinflammatory, antiischemic agent; neurodegenerative diseases; ocular disease, vision deffects |
| 07/31/2008 | US20080182981 Method and medicament for inhibiting the expression of a given gene |
| 07/31/2008 | US20080182977 Molecules associated with cell proliferation |
| 07/31/2008 | US20080182976 kit for detecting erythropoietin receptors which is capable of being activated comprising an antibody or fragment which activates formation or production of erythrocytes; treatment of anemia |
| 07/31/2008 | US20080182975 Framework-Patched Immunoglobulins |
| 07/31/2008 | US20080182973 Enhance cellular uptake of uncharged antisense oligonucleotide; forming a conjugate and arginine-rich peptide; oligonucleotide includes a string of contiguous guanine bases; substitute inosine base to limit the number of contiguous guanine bases to three; cancer, polycystic kidney disease, restenosis |
| 07/31/2008 | US20080182970 Using cypin in assays, diagnostics and treatment of cognitive disorders |
| 07/31/2008 | US20080182813 UNIVERSAL TARGET SEQUENCES FOR siRNA GENE SILENCING |
| 07/31/2008 | US20080182810 Antisense modulation of acyl coa cholesterol acyltransferase-2 expression |
| 07/31/2008 | US20080182809 Oligonucleotide sequences which bind biomolecules such as peptides, hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals |
| 07/31/2008 | US20080182808 Capable of inducing breakdown of mrna enzymes that break down connective tissue; particularly suited for treating degenerative skin disorders; pharmaceutical and cosmetic compositions for topical application and which contain the oligoribonucleotides |
| 07/31/2008 | US20080182807 gene therapy against tumors and cancer; expression vector includes insert into tumor an effective amount of polynucleotides encoding a functionally active p53, express p53 to first DNA damaging agent, contact tumor cell with first DNA damaging agent, and kill tumor cell |
| 07/31/2008 | US20080182796 Modified Cry3A toxins and nucleic acid sequences coding therefor |
| 07/31/2008 | US20080182794 Methods for treating breast cancer using nrif3 related molecules |
| 07/31/2008 | US20080182793 Polypeptide comprising oxidized lipid and/or carbohydrate binding activity for use as tool in diagnosis, prevention and treatment of thrombosis, atherosclerosis, inflammatory and bone disorders |
| 07/31/2008 | US20080182790 Nucleic acid encoding protein which has autoinducer inactivation activity; increase disease resistance in plants and animals; capable of efficient inactivation of N-acyl homoserine lactone autoinducers |
| 07/31/2008 | US20080182788 Compositions and Methods for Increasing Bone Mineralization |
| 07/31/2008 | US20080182783 Pharmacokinetics; host cell |
| 07/31/2008 | US20080182775 Administering analogs of luteinizing hormone-releasing hormone, leuprolide; inhibits testosterone secretion |
| 07/31/2008 | US20080182760 Oligonucleotide linkers comprising a variable cohesive portion and method for the preparation of polynucleotide libraries by using said linkers |
| 07/31/2008 | US20080182753 Polynucleotide molecule isolated or identified from Oryza sativa (rice); for expressing transgenes in plants, root tissues |
| 07/31/2008 | US20080182332 Optimized non-canonical zinc finger proteins |
| 07/31/2008 | US20080182331 Production of transgenic animals; targeted replacement of an endogenous gene; genetic trait expression; DNA gene inactivation construct |
| 07/31/2008 | US20080182327 cells containing proteic killer system based on the E. coli RelE polypeptide; gene coding for the antidote polypeptide is operably linked to a regulatory sequence that is different from the regulatory sequence controlling the gene coding for the cytotoxin polypeptide |
| 07/31/2008 | US20080182326 Sulfotransferase 1e1 sequence variants |
| 07/31/2008 | US20080182320 Two-step immunization procedure against chlamydia infection |
| 07/31/2008 | US20080182319 nucleotide sequence encoding a specific binding member or antibody VH or VL domain of a specific binding member that binds human eotaxin chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens; host cell |
| 07/31/2008 | US20080182316 Nucleic acids encoding opiate receptors |
| 07/31/2008 | US20080182314 Neuronal serine threonine protein kinase |
| 07/31/2008 | US20080182313 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening |
| 07/31/2008 | US20080182311 Novel trehalose synthase from Picrophilus torridus and methods of use thereof |
| 07/31/2008 | US20080182302 Open reading frames which encode polypeptides sufficient to direct the biosynthesis synthesis of a safracin molecule having improved properties and that could be used in the hemi-synthesis of new ecteinascidins compounds; combinatorial chemistry; antitumor agents; broad-spectrum antibiotics; bactericides |
| 07/31/2008 | US20080182300 Kit comprising RNA/DNA hybrid primer, template switch oligonucleotides (TSO) and cyclical replication of RNA sequences |
| 07/31/2008 | US20080182294 Recombinant clostridial neurotoxins (botulinum) having functional binding, translocation, and therapeutic domains; also an amino acid sequence susceptible to specific cleavage by proteases in vitro following expression as a single chain; inserts; therapeutic agents, transporter molecules; drug delivery |
| 07/31/2008 | US20080182283 Inhibitors of human plasmin derived from the kunitz domains |
| 07/31/2008 | US20080182279 Bacillus crystal protein having improved insecticidal activity; transgenic plant; polynucleotide segment having a sequence region that encodes an insecticidal hybrid delta-endotoxin protein; immunoassay |
| 07/31/2008 | US20080182275 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/31/2008 | US20080182274 Measuring simply and rapidly the expression of membrane protein on cell membrane; promotion/inhibition of the expression of membrane proteins |
| 07/31/2008 | US20080182269 utilize promoter hairpin constructs to suppress gene expression and thereby identify function of a gene of interest; useful for generating fertile parental plants that when crossed generate sterile progeny plants |
| 07/31/2008 | US20080182268 Schizophrenia associated genes, proteins and biallelic markers |
| 07/31/2008 | US20080182267 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 07/31/2008 | US20080182266 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 07/31/2008 | US20080182255 Gene Expression Profiling in Biopsied Tumor Tissues |
| 07/31/2008 | US20080182251 Ultra Low Strength Electric Field Network-Mediated Ex Vivo Gene, Protein and Drug Delivery in Cells |
| 07/31/2008 | US20080182249 Expression system for components of a desaturase complex is provided. The system includes expression of a desaturase and an oxidoreductase. The system may be used for expression of mycobacterial desaturases for expression of mammalian desaturases. |
| 07/31/2008 | US20080182245 Methods and Compositions Involving MicroRNA |
| 07/31/2008 | US20080182242 Dominant-negative alleles of human mismatch repair genes can be used to generate hypermutable cells and organisms. By introducing these genes into mammalian cells new cell lines with novel and useful properties can be prepared more efficiently than by relying on the natural rate of mutation |
| 07/31/2008 | US20080181918 Immunogens; vaccines; fusion proteins |
| 07/31/2008 | US20080181915 Cd40 ligand adjuvant for respiratory syncytial virus |
| 07/31/2008 | US20080181909 Chimeric immunomodulatory compounds and methods of using the same |
| 07/31/2008 | US20080181908 Genes and proteins, and their use |
| 07/31/2008 | US20080181907 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia |
| 07/31/2008 | US20080181906 For inducing neutralizing antibodies against HIV; hairpin motif; HIV gp120; hydrogen bonding |
| 07/31/2008 | US20080181903 Urodilatin; immunoglobulins; fusion proteins; pharmacokinetics |
| 07/31/2008 | US20080181902 Mutant protofibril for active immunisation; synuclein genes, proteins; Parkinson's disease; dementia |
| 07/31/2008 | US20080181901 Protein modulator of the plasma membrane Na,K-ATPase |
| 07/31/2008 | US20080181899 Blocks binding to Notch receptor; surface plasmon resonance |
| 07/31/2008 | US20080181895 SP16 protein |
| 07/31/2008 | US20080181892 Binding Domain Fusion Protein |
| 07/31/2008 | US20080181888 Polypeptides That Bind Br3 and Uses Thereof |
| 07/31/2008 | US20080181886 Polypeptides That Bind Baff And/Or April |
| 07/31/2008 | US20080181872 adeno-associated virus vector biodrug for Parkinson's disease, Huntington's disease, Alzheimer's disease, Down syndrome, rheumatoid arthritis, Crohn's disease; gene therapy of amyotrophic lateral sclerosis; drug creening; sustained release for prevent oxidative damage from superoxide buildup |
| 07/31/2008 | US20080181871 Focal calcium channel modulation |
| 07/31/2008 | DE102007005053A1 Verfahren zur enzymatischen Herstellung von Wasserstoffperoxid Process for the enzymatic production of hydrogen peroxide |
| 07/31/2008 | DE102007004283A1 Magnetic resonance contrast agent comprises a polypeptide that binds to a biological structure in the body of a mammal and comprises an amino acid sequence of a bacterial iron-binding protein |
| 07/31/2008 | DE102007003600A1 Laserdosimetrie für die Optoperforation einzelner Zellen Laserdosimetrie for optoperforation individual cells |
| 07/31/2008 | DE102006051623A1 Gene transfer into target cells in vivo comprises applying a gene transfer vector and a transduction enhancer at the same time and place |
| 07/31/2008 | DE102005011003B4 Verfahren und Mittel zur differentiellen Diagnose von Schilddrüsentumoren Method and means for the differential diagnosis of thyroid tumors |
| 07/31/2008 | CA2676651A1 Use of chick beta actin gene intron-1 |
| 07/31/2008 | CA2676529A1 Genetically recombinant antibody composition having enhanced effector activity |
| 07/31/2008 | CA2676481A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 07/31/2008 | CA2676174A1 Method for production of mesenchymal cell, method for production of tooth, and mesenchymal cell for formation of tooth |
| 07/31/2008 | CA2676143A1 Modification of exosomal components for use as a vaccine |
| 07/31/2008 | CA2676008A1 Compositions and methods for diagnosing and treating cancer |
| 07/31/2008 | CA2675764A1 Treating hepatitis c virus infection |
| 07/31/2008 | CA2675553A1 Genetically modified plants which synthesize a low amylose starch with increased swelling power |
| 07/31/2008 | CA2675344A1 Improvement of cell growth |
| 07/31/2008 | CA2675290A1 Dna methylation changes associated with major psychosis |
| 07/31/2008 | CA2674940A1 Use of r-genes as a selection marker in plant transformation and use of cisgenes in plant transformation |
| 07/31/2008 | CA2674213A1 Purification of fc-taci fusion proteins using the oilbody technology |
| 07/31/2008 | CA2673954A1 Production of a lipid acyltransferase from transformed bacillus licheniformis cells |
| 07/31/2008 | CA2672981A1 Novel gene disruptions, compositions and methods relating thereto |
| 07/31/2008 | CA2671866A1 Analysis chip and analysis method |
| 07/31/2008 | CA2671570A1 Transgene expression in avians |
| 07/31/2008 | CA2663796A1 Method for identification of organism by dna tag |
| 07/31/2008 | CA2657626A1 Viral inhibitory nucleotide sequences and vaccines |
| 07/30/2008 | EP1950312A1 Processes for isolating, amplifying and characterizing DNA |